S

SeaStar Medical Holding Corp
NASDAQ:ICU

Watchlist Manager
SeaStar Medical Holding Corp
NASDAQ:ICU
Watchlist
Price: 2.59 USD 884.79% Market Closed
Market Cap: 93.4m USD

SeaStar Medical Holding Corp
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

SeaStar Medical Holding Corp
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
SeaStar Medical Holding Corp
NASDAQ:ICU
Cash from Operating Activities
-$16m
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash from Operating Activities
$3.4B
CAGR 3-Years
9%
CAGR 5-Years
-1%
CAGR 10-Years
7%
Boston Scientific Corp
NYSE:BSX
Cash from Operating Activities
$4.6B
CAGR 3-Years
57%
CAGR 5-Years
25%
CAGR 10-Years
21%
Stryker Corp
NYSE:SYK
Cash from Operating Activities
$4.8B
CAGR 3-Years
23%
CAGR 5-Years
12%
CAGR 10-Years
18%
Abbott Laboratories
NYSE:ABT
Cash from Operating Activities
$9.1B
CAGR 3-Years
-4%
CAGR 5-Years
7%
CAGR 10-Years
10%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Operating Activities
$3B
CAGR 3-Years
22%
CAGR 5-Years
16%
CAGR 10-Years
16%
No Stocks Found

SeaStar Medical Holding Corp
Glance View

Market Cap
88.3m USD
Industry
Health Care

Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company is headquartered in Tampa, Florida. The company went IPO on 2021-01-26. The firm is focused on redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. The firm's technologies rely on science to provide life-saving solutions to critically ill patients. The firm is engaged in developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

ICU Intrinsic Value
0.14 USD
Overvaluation 95%
Intrinsic Value
Price
S

See Also

What is SeaStar Medical Holding Corp's Cash from Operating Activities?
Cash from Operating Activities
-16m USD

Based on the financial report for Dec 31, 2024, SeaStar Medical Holding Corp's Cash from Operating Activities amounts to -16m USD.

What is SeaStar Medical Holding Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-46%

Over the last year, the Cash from Operating Activities growth was -56%. The average annual Cash from Operating Activities growth rates for SeaStar Medical Holding Corp have been -46% over the past three years .

Back to Top